CSI Market
Sign In | Register

Camp4 Therapeutics (CAMP) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CAMP Annual Cash Flow →
This cash flow overview for Camp4 Therapeutics spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-51.86
Depreciation & amortization2.04
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation3.40
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Excess Tax Benefits From Share Based Compensation Operating Activities-
Impairment Loss And Equity In Net Loss Of Affiliate-1.21
Impairment Of Operating Lease Right Of Use Assets6.19
Noncash Operating Lease Cost-
Impairment Loss On Equity Investment0.03
Increase Decrease In Operating Lease Liabilities-
Income taxes0.00
Trading Securities, Change in Unrealized Holding Gain (Loss)0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.91
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-1.82
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.33
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities24.00
Discontinued operations0.00
Net Cash flow from Operating Activities-23.67
Investing Activities
Capital Expenditures-0.13
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Payments For Navman Wirless Asset Purchase Agreement-
Business Combination Consideration Transferred-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Payments for Advance to Affiliate0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.13
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.06
Proceeds From Issuance Of Subordinated Debt And Warrants-
Proceeds From Repayments Of Bank Debt-
Payments To Purchase Capped Call-
Proceeds From Unwind Of Notes Hedges And Warrants-
Proceeds From Stock Options Exercised And Contributions To Employee Stock Purchase Plan-
Proceeds From Paycheck Protection Program Loan-
Repayment Of Paycheck Protection Program Loan-
Payments Of Issuance Costs Of Line Of Credit-
Repurchase Of Convertible Notes-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.06
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-23.80
Total Cash Flow-23.74
4 historic quarters locked

Sign in to unlock the full Camp4 Therapeutics cash flow history.

Sign In Create Free Account

About Camp4 Therapeutics Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-056760

Figures are derived from filed reports and may be restated. Historical data is subject to revision.